triazoles has been researched along with AIDS, Simian in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Grobler, JA; Markowitz, M | 1 |
| Aubert, R; Aung, W; Bachman, S; García-Lerma, JG; Heneine, W; Kersh, E; Martin, A; Massud, I; Mitchell, J; Pau, CP; Solomon Tsegaye, T | 1 |
| Adams, RJ; Avery, LB; Beck, SE; Dorsey, JL; Hubbard, W; Kelly, KM; Mankowski, JL; Metcalf Pate, KA; Queen, SE; Tarwater, PM | 1 |
| Adams, RJ; Beck, SE; Bedja, D; Graham, DR; Kelly, KM; Lyashkov, A; Mankowski, JL; Metcalf Pate, KA; Paolocci, N; Queen, SE; Tarwater, PM; Tocchetti, CG | 1 |
| Abid, S; Adnot, S; Amsellem, V; Bobe, R; Combadière, C; Delcroix, M; Dubois-Randé, JL; Gary-Bobo, G; Gladwin, MT; Houssaini, A; Lipskaia, L; Marcos, E; Mouraret, N; Norris, KA; Parpaleix, A; Poupel, L; Quarck, R; Saker, M | 1 |
| Anderson, PL; Bushman, LR; Chuong, D; Dobard, CW; Garcia-Lerma, JG; Hanson, D; Heneine, W; McGowan, I; Pau, CP; Rohan, L; Sharma, S; Taylor, A; Wang, L | 1 |
| Chen, J; Li, L; Qin, C; Ren, Y; Wan, Y; Wang, J; Wang, W; Wei, Q; Xu, J; Zhang, X | 1 |
| Chung, HK; Galmin, L; Pal, R; Rose, N; Suschak, J | 1 |
| Dufour, J; Green, LC; Ketas, TJ; Klasse, PJ; Moore, JP; Moroney-Rasmussen, T; Veazey, RS | 1 |
| Boyd, P; Doyle, LA; Fetherston, SM; Geer, L; Goldman, L; Ketas, TJ; Klasse, PJ; Lowry, D; Major, I; Malcolm, RK; Moore, JP; Murphy, DJ; Rasmussen, KK; Shattock, RJ; Veazey, RS | 1 |
| Barouch, DH; Dufour, J; Klasse, PJ; Moore, JP; Veazey, RS | 1 |
| Acosta, EP; Barreca, ML; Chirullo, B; Collins, M; Della Corte, A; Greenhouse, J; Iraci, N; Lewis, MG; Norelli, S; Savarino, A; Shytaj, IL; Yalley-Ogunro, J | 1 |
| Forbes, CJ; Geer, L; Goldman, L; Klasse, PJ; Malcolm, RK; Moore, JP; Veazey, RS | 1 |
1 review(s) available for triazoles and AIDS, Simian
| Article | Year |
|---|---|
Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1.
Topics: Animals; Anti-HIV Agents; Deoxyadenosines; Drug Combinations; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; Lamivudine; Macaca mulatta; Pre-Exposure Prophylaxis; Pyridones; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Triazoles; Viral Load | 2020 |
12 other study(ies) available for triazoles and AIDS, Simian
| Article | Year |
|---|---|
Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues.
Topics: Animals; Anti-Retroviral Agents; Chemoprevention; Cyclohexanes; Female; Intestinal Mucosa; Macaca; Male; Maraviroc; Plasma; Rectum; Simian Acquired Immunodeficiency Syndrome; Treatment Failure; Triazoles | 2013 |
Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Brain; CCR5 Receptor Antagonists; Chemokine CCL2; Cyclohexanes; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Macaca mulatta; Maraviroc; Plasma; Real-Time Polymerase Chain Reaction; Receptors, Cell Surface; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Triazoles; Tumor Necrosis Factor-alpha; Viral Load | 2013 |
CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Diastole; Disease Models, Animal; Echocardiography, Doppler; Heart Ventricles; HIV Fusion Inhibitors; Ligands; Macaca mulatta; Maraviroc; Myocytes, Cardiac; Receptors, CCR5; Signal Transduction; Simian Acquired Immunodeficiency Syndrome; Triazoles; Ventricular Dysfunction; Ventricular Function; Viral Load | 2014 |
CCR5 as a treatment target in pulmonary arterial hypertension.
Topics: Animals; CCR5 Receptor Antagonists; Cell Proliferation; Cells, Cultured; Cyclohexanes; Disease Models, Animal; Familial Primary Pulmonary Hypertension; HIV Fusion Inhibitors; HIV Infections; Humans; Hypertension, Pulmonary; Hypoxia; Macaca mulatta; Macrophages; Male; Maraviroc; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Pulmonary Artery; Receptors, CCR5; Simian Acquired Immunodeficiency Syndrome; Triazoles | 2014 |
Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
Topics: Administration, Topical; Animals; Anti-HIV Agents; Cross-Over Studies; Cyclohexanes; Disease Models, Animal; Disease Transmission, Infectious; Gels; Macaca; Maraviroc; Placebos; Simian Acquired Immunodeficiency Syndrome; Tenofovir; Treatment Outcome; Triazoles | 2015 |
Mucosal Topical Microbicide Candidates Exert Influence on the Subsequent SIV Infection and Survival by Regulating SIV-Specific T-Cell Immune Responses.
Topics: Administration, Rectal; Animals; Anti-Infective Agents, Local; CD4-Positive T-Lymphocytes; Cyclohexanes; Disease Progression; Gene Expression Profiling; Humans; Immunity, Cellular; Macaca mulatta; Maraviroc; Mucous Membrane; Oligonucleotide Array Sequence Analysis; Peptides; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Survival Rate; Tenofovir; Triazoles; Viral Load | 2016 |
Characterization of a SHIV162P3 variant evolved in an infected rhesus macaque with persistent plasma viremia.
Topics: Amino Acid Substitution; Animals; Anti-HIV Agents; Antibodies, Neutralizing; CD4 Lymphocyte Count; Cyclohexanes; Gene Products, env; HIV Antibodies; Macaca mulatta; Male; Maraviroc; Mutation, Missense; Plasma; Sequence Analysis, DNA; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Triazoles; Viremia | 2010 |
Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Cyclohexanes; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Macaca mulatta; Maraviroc; Receptors, CCR5; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Treatment Outcome; Triazoles; Vaginal Diseases; Virus Internalization; Virus Replication | 2010 |
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Biopsy; CCR5 Receptor Antagonists; Chromatography, High Pressure Liquid; Contraceptive Devices, Female; Cyclohexanes; Delayed-Action Preparations; Female; HIV Infections; HIV-1; Humans; Longitudinal Studies; Macaca mulatta; Maraviroc; Medroxyprogesterone Acetate; Pyrazoles; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tissue Distribution; Triazoles; Vagina; Valine; Virus Internalization | 2012 |
Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.
Topics: Administration, Intravaginal; AIDS Vaccines; Animals; Anti-Infective Agents; CCR5 Receptor Antagonists; Cyclohexanes; Drug Therapy, Combination; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Macaca mulatta; Maraviroc; RNA, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Treatment Outcome; Triazoles; Viral Load | 2012 |
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.
Topics: Adenine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cyclohexanes; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Flow Cytometry; Fluorescent Antibody Technique; Macaca mulatta; Maraviroc; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Sulfonamides; T-Lymphocyte Subsets; Tenofovir; Triazoles; Viral Load; Viremia | 2012 |
Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques.
Topics: Administration, Intravaginal; Animals; Body Fluids; Cyclohexanes; Female; HIV Fusion Inhibitors; Macaca mulatta; Maraviroc; Plasma; Simian Acquired Immunodeficiency Syndrome; Time Factors; Triazoles; Vagina; Vaginal Creams, Foams, and Jellies | 2013 |